In view of the above phenomena, we suspected that HERV-K (HML-2) has an important ability to activate interferon, thus we explored whether the activation of interferon in moderate COVID-19 patients and severe COVID-19 patients is related to HERV-K (HML-2). This evidence concerns the gene CLEC10A and COVID-19.